Clinical Trial Update: Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant [NA]

View source ↗

Summary

The clinical trial evaluating rituximab desensitization for patients on the kidney transplant waiting list with end-stage renal disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: End Stage Renal Disease | NA | Status: WITHDRAWN